These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3902988)

  • 21. Activation of the plasma kallikrein-kinin system by Candida albicans proteinase.
    Kaminishi H; Tanaka M; Cho T; Maeda H; Hagihara Y
    Infect Immun; 1990 Jul; 58(7):2139-43. PubMed ID: 2194962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of Candida albicans.
    Cadicamo CD; Mortier J; Wolber G; Hell M; Heinrich IE; Michel D; Semlin L; Berger U; Korting HC; Höltje HD; Koksch B; Borelli C
    Biochem Pharmacol; 2013 Apr; 85(7):881-7. PubMed ID: 23262278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of proteinase inhibitors on the cutaneous lesion of Sporothrix schenckii inoculated hairless mice.
    Lei PC; Yoshiike T; Ogawa H
    Mycopathologia; 1993 Aug; 123(2):81-5. PubMed ID: 8264771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors.
    Gruber A; Berlit J; Speth C; Lass-Flörl C; Kofler G; Nagl M; Borg-von Zepelin M; Dierich MP; Würzner R
    Immunobiology; 1999 Sep; 201(1):133-44. PubMed ID: 10532286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biochemical properties of keratinolytic proteinases produced by Candida albicans].
    Matsuda K; Hattori M; Suzuki Y; Sato T; Ogawa H
    Nihon Hifuka Gakkai Zasshi; 1983 Mar; 93(4):463-6. PubMed ID: 6350658
    [No Abstract]   [Full Text] [Related]  

  • 26. Multiple effects of green tea catechin on the antifungal activity of antimycotics against Candida albicans.
    Hirasawa M; Takada K
    J Antimicrob Chemother; 2004 Feb; 53(2):225-9. PubMed ID: 14688042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro activity of fluconazole, a novel bistriazole antifungal agent].
    Yamaguchi H; Uchida K; Kawasaki K; Matsunaga T
    Jpn J Antibiot; 1989 Jan; 42(1):1-16. PubMed ID: 2540356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced anti-Candida activity of neutrophils and azole antifungal agents in the presence of lactoferrin-related compounds.
    Wakabayashi H; Okutomi T; Abe S; Hayasawa H; Tomita M; Yamaguchi H
    Adv Exp Med Biol; 1998; 443():229-37. PubMed ID: 9781363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of pH and human saliva on protease production by Candida albicans.
    Germaine GR; Tellefson LM
    Infect Immun; 1981 Jan; 31(1):323-6. PubMed ID: 7011995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for the participation of proteinases released by Candida albicans in the early killing of peritoneal macrophages in vitro.
    de-Andrade GM; Felipe I
    Braz J Med Biol Res; 1992; 25(2):167-74. PubMed ID: 1339513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Difference in killing activity of caspofungin and paradoxical growth between Candida albicans and C. krusei clinical isolates in different media.
    Varga I; Sóczó G; Kardos G; Kemény-Beke A; Kelentey B; Márton I; Majoros L
    J Chemother; 2009 Feb; 21(1):36-41. PubMed ID: 19297270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of pH on the antifungal susceptibility of vaginal Candida albicans.
    Liu W; Zhang X; Liu Z; Luo X
    Int J Gynaecol Obstet; 2011 Sep; 114(3):278-80. PubMed ID: 21696733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
    Odds FC; Cockayne A; Hayward J; Abbott AB
    J Gen Microbiol; 1985 Oct; 131(10):2581-9. PubMed ID: 2999296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of subinhibitory concentrations of conventional and experimental antifungal drugs on the expression of the iC3b binding protein in Candida albicans strains during filamentation.
    Bujdáková H; Lell CP; Gruber A; Langgartner M; Spötl L; Kurisková S; Klobusický M; Dierich MP; Würzner R
    FEMS Immunol Med Microbiol; 1999 Oct; 26(1):1-10. PubMed ID: 10518038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fungicidal effect of human lactoferrin against Candida albicans.
    Soukka T; Tenovuo J; Lenander-Lumikari M
    FEMS Microbiol Lett; 1992 Jan; 69(3):223-8. PubMed ID: 1555756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetic and mechanistic analysis of the association and dissociation of inhibitors interacting with secreted aspartic acid proteases 1 and 2 from Candida albicans.
    Backman D; Danielson UH
    Biochim Biophys Acta; 2003 Mar; 1646(1-2):184-95. PubMed ID: 12637026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
    Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Action of clotrimazole on Candida albicans.
    Beggs WH
    J Antimicrob Chemother; 1995 Oct; 36(4):742-3. PubMed ID: 8591954
    [No Abstract]   [Full Text] [Related]  

  • 39. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spermidine-analogous triamines suppressed the growth of Candida albicans.
    Takahashi E; Oono S; Yamamoto S; Arimoto S; Negishi T; Okamoto K
    Biol Pharm Bull; 2013; 36(9):1440-7. PubMed ID: 23995655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.